The need
Accurate + Predictive + Non-Invasive
Mission critical cardiac monitoring for critical care, operating rooms and heart failure patients has historically required invasive pulmonary catheters and implants. We aim to change that.
The platform
Next Generation Capabilities
Our approach combines a unique physiological signal, off-the-shelf sensors, and cloud computing to predict patient health.
The results
Game Changing Potential
Our early clinical studies show that Respirix can already predict 87% of the signal in an implant that is the standard of care for heart failure monitoring.
Team
Eric Kriegstein
CEO
Daniel Burnett
Chairman & Co-Founder
Michael Jaasma
CSO
Bryan Nowroozi
Data Science
Alex Vergara
Engineering
Carin Lindquist
Clinical
Advisors
Michael Lesh
MD
Riccardo Turchetto
Geoffrey Tison
MD, MPH
Paul L. Marino
MD, PhD
Support From
